Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL337450

TAS-109
🧪 Phase II
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
🧪 Phase II
N#C[C@H]1[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O
ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID CHEMBL337450
Name TAS-109
Phase Phase II
Structure Type MOL
InChI Key DCYBPMFXJCWXNB-JWIUVKOKSA-N

Known Names

Cndac Deoxycytidine analogue tas-109 Radgocitabine Tas 109 Tas-109
5
Targets
15
Activities
1
Assay Types
10
PK Parameters
20
Publications
5
Known Names
1
Indications

Molecular Properties

252.2
MW (Da)
-1.78
ALogP
8
HBA
3
HBD
134.4
PSA (Ų)
0.57
QED
0
Ro5 Violations
2
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Single Enantiomer

Flags

Natural Product

Extended Properties

Molecular Formula C10H12N4O4
MW 252.23
Aromatic Rings 1
Heavy Atoms 18
NP-Likeness 1.09

Indications

Colorectal Neoplasms

Activity Summary

IC50 15 meas. best 6.89

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Human gammaherpesvirus 8
CHEMBL612780
 IC50 6.89 6.765 130.0 2
MKN-74
CHEMBL614048
 IC50 6.82 6.0367 150.0 3
WiDr
CHEMBL614647
 IC50 6.8 6.03 157.0 3
ADMET
CHEMBL612558
 IC50 6.68 6.68 210.0 1
SBC-5
CHEMBL614896
 IC50 6.65 6.0767 222.0 3

Pharmacokinetic Data

Parameter Value Units Species
T1/2 38.0 hr -
T1/2 4.0 hr -
T1/2 1.0 hr -
T1/2 0.45 hr -
T1/2 0.14 hr -
T1/2 0.033 hr -
T1/2 0.009 hr -
T1/2 1.0 hr -
T1/2 0.5 hr -
T1/2 0.35 hr -

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Human gammaherpesvirus 8 IC50 = 130.0 nM 6.89 Cytotoxicity against Kaposi's sarcoma-associated herpesvirus infected BC2 cells ... 17402726
MKN-74 IC50 = 150.0 nM 6.82 In Vitro cell growth inhibitory activity of CNDAC Stomach Carcinoma MKN-74 (1*10... 7650692
WiDr IC50 = 157.0 nM 6.8 In Vitro cell growth inhibitory activity of CNDAC against Human Colon Carcinoma ... 7650692
MKN-74 IC50 = 206.0 nM 6.69 In Vitro cell growth inhibitory activity of CNDAC Stomach Carcinoma MKN-74 (1*10... 7650692
ADMET IC50 = 210.0 nM 6.68 Cytotoxicity against DG75 cells after 120 hrs by MTT assay 17402726
SBC-5 IC50 = 222.0 nM 6.65 In Vitro cell growth inhibitory activity of CNDAC against Small Cell Lung Carcin... 7650692
Human gammaherpesvirus 8 IC50 = 230.0 nM 6.64 Cytotoxicity against Kaposi's sarcoma-associated herpesvirus infected BC3 cells ... 17402726
WiDr IC50 = 306.0 nM 6.51 In Vitro cell growth inhibitory activity of CNDAC against Human Colon Carcinoma ... 7650692
SBC-5 IC50 = 367.0 nM 6.43 In Vitro cell growth inhibitory activity of CNDAC against Small Cell Lung Carcin... 7650692
SBC-5 IC50 = 7140.0 nM 5.15 In Vitro cell growth inhibitory activity of CNDAC against Small Cell Lung Carcin... 7650692
WiDr IC50 = 16500.0 nM 4.78 In Vitro cell growth inhibitory activity of CNDAC against Human Colon Carcinoma ... 7650692
MKN-74 IC50 = 24900.0 nM 4.6 In Vitro cell growth inhibitory activity of CNDAC Stomach Carcinoma MKN-74 (1*10... 7650692

Literature References

PubMed DOI Target Context # Activities
7650692 10.1021/jm00017a023 ADMET 40
7650692 10.1021/jm00017a023 Mus musculus 16
- 10.1016/0960-894X(96)00162-X Mus musculus 9
7650692 10.1021/jm00017a023 MKN-74 4
7650692 10.1021/jm00017a023 SBC-5 4
7650692 10.1021/jm00017a023 WiDr 4
17402726 10.1021/jm070032y Human gammaherpesvirus 8 2
1895307 10.1021/jm00113a034 PC-3 1
1895307 10.1021/jm00113a034 PC-13 1
1895307 10.1021/jm00113a034 PC-9 1
1895307 10.1021/jm00113a034 PC-8 1
1895307 10.1021/jm00113a034 ST-KM-1 1
17402726 10.1021/jm070032y BC-3 1
1895307 10.1021/jm00113a034 SK-ES1 1
1895307 10.1021/jm00113a034 KHOS-321H 1
1895307 10.1021/jm00113a034 OST 1
1895307 10.1021/jm00113a034 MKN-74 1
1895307 10.1021/jm00113a034 MKN-28 1
1895307 10.1021/jm00113a034 MKN-7 1
1895307 10.1021/jm00113a034 MKN-1 1

Data from ChEMBL 36 via Core Engine